Discussion: Is it possible to identify patients with viral hepatitis (A, B, C, D, E) in advance and dramatically reduce the number of liver transplants?

  1. Home
  2. FORUMS
  3. Chronic liver diseases and cirrhosis.

Is it possible to identify patients with viral hepatitis (A, B, C, D, E) in advance and dramatically reduce the number of liver transplants?

The risk population that may have viral hepatitis is known to medicine. (Some viruses have an effective vaccine.) A blood test (relatively simple) can detect the antibody to the virus in the blood. The viral load test is rather expensive but marginal to the economic damage created by the disease. I was infected with type C viral hepatitis (no vaccine). In my case, the state insurance covered the cost of treatment, which is one of the most expensive available. (approximately $100,000 for 6 months of treatment) Why don't countries initiate an appeal to the at-risk population to get tested? No one is hurrying to "kill chickens that lay golden eggs." Around the treatment of liver diseases, there is a vast industry.

Link: Preventive Medicine is Crucial to Optimize Healthcare.
https://www.sf-healing.com/page/238 (Copy & Paste)

May interest you:
Add New Post
WhatsApp
We use cookies to improve the user experience on the site. Learn moreI Agree